These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32678679)

  • 21. [Epidemiology of infections associated to "Burkholderia cepacia complex" in the course of cystic fibrosis].
    Meghdas I; Loïez C; Baïda N; Dabboussi F; Hamze M; Husson MO; Izard D
    Arch Pediatr; 2004 Apr; 11(4):360-6. PubMed ID: 15139322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors influencing acquisition of Burkholderia cepacia complex organisms in patients with cystic fibrosis.
    Ramsay KA; Butler CA; Paynter S; Ware RS; Kidd TJ; Wainwright CE; Bell SC
    J Clin Microbiol; 2013 Dec; 51(12):3975-80. PubMed ID: 24048536
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence of Burkholderia contaminans at a cystic fibrosis centre with an unusually high representation of Burkholderia cepacia during 15 years of epidemiological surveillance.
    Coutinho CP; Barreto C; Pereira L; Lito L; Melo Cristino J; Sá-Correia I
    J Med Microbiol; 2015 Aug; 64(8):927-935. PubMed ID: 26002942
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis, Canada.
    Speert DP; Henry D; Vandamme P; Corey M; Mahenthiralingam E
    Emerg Infect Dis; 2002 Feb; 8(2):181-7. PubMed ID: 11897071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Infection with Burkholderia cepacia complex genomovars in patients with cystic fibrosis: virulent transmissible strains of genomovar III can replace Burkholderia multivorans.
    Mahenthiralingam E; Vandamme P; Campbell ME; Henry DA; Gravelle AM; Wong LT; Davidson AG; Wilcox PG; Nakielna B; Speert DP
    Clin Infect Dis; 2001 Nov; 33(9):1469-75. PubMed ID: 11588691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic Stenotrophomonas maltophilia infection and mortality or lung transplantation in cystic fibrosis patients.
    Waters V; Atenafu EG; Lu A; Yau Y; Tullis E; Ratjen F
    J Cyst Fibros; 2013 Sep; 12(5):482-6. PubMed ID: 23294530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical outcome of Burkholderia cepacia complex infection in cystic fibrosis adults.
    Courtney JM; Dunbar KE; McDowell A; Moore JE; Warke TJ; Stevenson M; Elborn JS
    J Cyst Fibros; 2004 Jun; 3(2):93-8. PubMed ID: 15463892
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular typing of Burkholderia cepacia complex isolated from patients attending an Italian Cystic Fibrosis Centre.
    Teri A; Sottotetti S; Biffi A; Girelli D; D'Accico M; Arghittu M; Colombo C; Corti F; Pizzamiglio G; Cariani L
    New Microbiol; 2018 Apr; 41(2):141-144. PubMed ID: 29498745
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibiotic treatment for Burkholderia cepacia complex in people with cystic fibrosis experiencing a pulmonary exacerbation.
    Horsley A; Jones AM
    Cochrane Database Syst Rev; 2012 Oct; 10():CD009529. PubMed ID: 23076960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Burkholderia cepacia complex in cystic fibrosis in a Brazilian reference center.
    Dentini P; Marson FAL; Bonadia LC; Bertuzzo CS; Ribeiro AF; Levy CE; Ribeiro JD
    Med Microbiol Immunol; 2017 Dec; 206(6):447-461. PubMed ID: 28965239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Accurate identification of members of the Burkholderia cepacia complex in cystic fibrosis sputum.
    Martinucci M; Roscetto E; Iula VD; Votsi A; Catania MR; De Gregorio E
    Lett Appl Microbiol; 2016 Mar; 62(3):221-9. PubMed ID: 26671758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for Burkholderia cepacia complex colonization and infection among patients with cystic fibrosis.
    Walsh NM; Casano AA; Manangan LP; Sinkowitz-Cochran RL; Jarvis WR
    J Pediatr; 2002 Oct; 141(4):512-7. PubMed ID: 12378190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypermutation in Burkholderia cepacia complex is mediated by DNA mismatch repair inactivation and is highly prevalent in cystic fibrosis chronic respiratory infection.
    Martina P; Feliziani S; Juan C; Bettiol M; Gatti B; Yantorno O; Smania AM; Oliver A; Bosch A
    Int J Med Microbiol; 2014 Nov; 304(8):1182-91. PubMed ID: 25217078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Major Aspects of Burkholderia gladioli and Burkholderia cepacia Infections in Children.
    Bedir Demirdag T; Ozkaya Parlakay A; Aygar IS; Gulhan B; Kanik Yuksek S
    Pediatr Infect Dis J; 2020 May; 39(5):374-378. PubMed ID: 32118858
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Burkholderia cepacia complex: a contraindication to lung transplantation in cystic fibrosis?
    LiPuma JJ
    Transpl Infect Dis; 2001 Sep; 3(3):149-60. PubMed ID: 11493397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Burkholderia cenocepacia in cystic fibrosis: epidemiology and molecular mechanisms of virulence.
    Drevinek P; Mahenthiralingam E
    Clin Microbiol Infect; 2010 Jul; 16(7):821-30. PubMed ID: 20880411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distribution of Burkholderia cepacia complex species among isolates recovered from persons with or without cystic fibrosis.
    Reik R; Spilker T; Lipuma JJ
    J Clin Microbiol; 2005 Jun; 43(6):2926-8. PubMed ID: 15956421
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Burkholderia cepacia complex in cystic fibrosis: frequency of strain replacement during chronic infection.
    Bernhardt SA; Spilker T; Coffey T; LiPuma JJ
    Clin Infect Dis; 2003 Sep; 37(6):780-5. PubMed ID: 12955638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Bacteria of the Burkholderia cepacia complex: epidemiology and diagnosis of infection in patients with cystic fibrosis].
    Dřevínek P
    Epidemiol Mikrobiol Imunol; 2014 Feb; 63(1):18-26. PubMed ID: 24730990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Management of initial colonisations with Burkholderia species in France, with retrospective analysis in five cystic fibrosis Centres: a pilot study.
    Gruzelle V; Guet-Revillet H; Segonds C; Bui S; Macey J; Chiron R; Michelet M; Murris-Espin M; Mittaine M
    BMC Pulm Med; 2020 Jun; 20(1):159. PubMed ID: 32503487
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.